[1]
Villafuerte-Gutierrez P,Villalon L,Losa JE,Henriquez-Camacho C, Treatment of febrile neutropenia and prophylaxis in hematologic malignancies: a critical review and update. Advances in hematology. 2014; [PubMed PMID: 25525436]
[2]
Rivera-Salgado D,Valverde-Muñoz K,Ávila-Agüero ML, [Febrile neutropenia in cancer patients: management in the emergency room]. Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia. 2018; [PubMed PMID: 29652973]
[3]
Hakim H,Flynn PM,Knapp KM,Srivastava DK,Gaur AH, Etiology and clinical course of febrile neutropenia in children with cancer. Journal of pediatric hematology/oncology. 2009 Sep; [PubMed PMID: 19644403]
[4]
Yapici O,Gunseren F,Yapici H,Merdin A,Yaylali ÜÜ,Merdin FA, Evaluation of febrile neutropenic episodes in adult patients with solid tumors. Molecular and clinical oncology. 2016 Mar; [PubMed PMID: 26998287]
[6]
Karimi F,Ashrafi F,Moghaddas A,Derakhshandeh A, Management of Febrile Neutropenia: A Description of Clinical and Microbiological Findings by Focusing on Risk Factors and Pitfalls. Journal of research in pharmacy practice. 2018 Jul-Sep; [PubMed PMID: 30211240]
[7]
van der Velden WJ,Herbers AH,Netea MG,Blijlevens NM, Mucosal barrier injury, fever and infection in neutropenic patients with cancer: introducing the paradigm febrile mucositis. British journal of haematology. 2014 Nov; [PubMed PMID: 25196917]
[8]
Klastersky J,de Naurois J,Rolston K,Rapoport B,Maschmeyer G,Aapro M,Herrstedt J, Management of febrile neutropaenia: ESMO Clinical Practice Guidelines. Annals of oncology : official journal of the European Society for Medical Oncology. 2016 Sep; [PubMed PMID: 27664247]
[9]
Fontanella C,Bolzonello S,Lederer B,Aprile G, Management of breast cancer patients with chemotherapy-induced neutropenia or febrile neutropenia. Breast care (Basel, Switzerland). 2014 Apr; [PubMed PMID: 25404882]
[10]
Ferreira JN,Correia LRBR,Oliveira RM,Watanabe SN,Possari JF,Lima AFC, Managing febrile neutropenia in adult cancer patients: an integrative review of the literature. Revista brasileira de enfermagem. 2017 Nov-Dec; [PubMed PMID: 29160494]
[11]
Libuit J,Whitman A,Wolfe R,Washington CS, Empiric vancomycin use in febrile neutropenic oncology patients. Open forum infectious diseases. 2014 Mar; [PubMed PMID: 25734080]
[12]
Chung SJ,Miller RA,Permpalung N,Baker AW,Diehl LF,Rizzieri DA,Alexander BD, Fluoroquinolone prophylaxis reduces febrile neutropenia, bloodstream infections from mucosal translocations, and intensive care admissions in high risk hematological patients, a single center experience. Leukemia [PubMed PMID: 30126315]
[13]
Yoshida M,Ohno R, Antimicrobial prophylaxis in febrile neutropenia. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2004 Jul 15; [PubMed PMID: 15250025]
[14]
Neumann S,Krause SW,Maschmeyer G,Schiel X,von Lilienfeld-Toal M, Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematological malignancies and solid tumors : guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Annals of hematology. 2013 Apr; [PubMed PMID: 23412562]
[15]
Hashiguchi Y,Kasai M,Fukuda T,Ichimura T,Yasui T,Sumi T, Chemotherapy-induced neutropenia and febrile neutropenia in patients with gynecologic malignancy. Anti-cancer drugs. 2015 Nov; [PubMed PMID: 26267078]
[16]
Ahn S,Lee YS, Predictive factors for poor prognosis febrile neutropenia. Current opinion in oncology. 2012 Jul; [PubMed PMID: 22476191]
[17]
Rosa RG,Goldani LZ, Cohort study of the impact of time to antibiotic administration on mortality in patients with febrile neutropenia. Antimicrobial agents and chemotherapy. 2014 Jul; [PubMed PMID: 24752269]
[18]
Monroe K,Cohen CT,Whelan K,King A,Maloney L,Deason J,Nichols JC,Friedman GK,Kutny M,Hayes L, Quality Initiative to Improve time to Antibiotics for Febrile Pediatric Patients with Potential Neutropenia. Pediatric quality [PubMed PMID: 30229205]